REGN logo

REGN CAPEX

annual CAPEX:

$881.60M-$44.80M(-4.84%)
December 31, 2024

Summary

  • As of today (May 29, 2025), REGN annual capital expenditures is $881.60 million, with the most recent change of -$44.80 million (-4.84%) on December 31, 2024.
  • During the last 3 years, REGN annual CAPEX has risen by +$329.70 million (+59.74%).
  • REGN annual CAPEX is now -45.48% below its all-time high of $1.62 billion, reached on December 31, 2022.

Performance

REGN CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

quarterly CAPEX:

$271.50M+$4.50M(+1.69%)
March 31, 2025

Summary

  • As of today (May 29, 2025), REGN quarterly capital expenditures is $271.50 million, with the most recent change of +$4.50 million (+1.69%) on March 31, 2025.
  • Over the past year, REGN quarterly CAPEX has increased by +$109.70 million (+67.80%).
  • REGN quarterly CAPEX is now -74.61% below its all-time high of $1.07 billion, reached on September 30, 2022.

Performance

REGN quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

TTM CAPEX:

$991.30M+$109.70M(+12.44%)
March 31, 2025

Summary

  • As of today (May 29, 2025), REGN TTM capital expenditures is $991.30 million, with the most recent change of +$109.70 million (+12.44%) on March 31, 2025.
  • Over the past year, REGN TTM CAPEX has increased by +$182.20 million (+22.52%).
  • REGN TTM CAPEX is now -43.49% below its all-time high of $1.75 billion, reached on March 31, 2023.

Performance

REGN TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

REGN CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-4.8%+67.8%+22.5%
3 y3 years+59.7%+91.5%+71.4%
5 y5 years+105.2%+59.6%+88.7%

REGN CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-45.5%+59.7%-74.6%+102.8%-43.5%+71.4%
5 y5-year-45.5%+105.2%-74.6%+135.5%-43.5%+88.7%
alltimeall time-45.5%>+9999.0%-74.6%+644.1%-43.5%+2173.8%

REGN CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$271.50M(+1.7%)
$991.30M(+12.4%)
Dec 2024
$881.60M(-4.8%)
$267.00M(+10.4%)
$881.60M(-5.0%)
Sep 2024
-
$241.90M(+14.7%)
$928.10M(+4.7%)
Jun 2024
-
$210.90M(+30.3%)
$886.10M(+9.5%)
Mar 2024
-
$161.80M(-48.4%)
$809.10M(-12.7%)
Dec 2023
$926.40M(-42.7%)
$313.50M(+56.8%)
$926.40M(+7.1%)
Sep 2023
-
$199.90M(+49.3%)
$865.10M(-50.1%)
Jun 2023
-
$133.90M(-52.0%)
$1.73B(-1.1%)
Mar 2023
-
$279.10M(+10.7%)
$1.75B(+8.5%)
Dec 2022
$1.62B(+193.0%)
$252.20M(-76.4%)
$1.62B(+6.4%)
Sep 2022
-
$1.07B(+596.2%)
$1.52B(+160.4%)
Jun 2022
-
$153.60M(+8.3%)
$583.50M(+0.9%)
Mar 2022
-
$141.80M(-8.5%)
$578.40M(+4.8%)
Dec 2021
$551.90M(-10.2%)
$154.90M(+16.3%)
$551.90M(-1.2%)
Sep 2021
-
$133.20M(-10.3%)
$558.40M(-3.5%)
Jun 2021
-
$148.50M(+28.8%)
$578.40M(+3.3%)
Mar 2021
-
$115.30M(-28.6%)
$559.80M(-8.9%)
Dec 2020
$614.60M(+43.1%)
$161.40M(+5.4%)
$614.60M(+3.8%)
Sep 2020
-
$153.20M(+17.9%)
$592.20M(+5.6%)
Jun 2020
-
$129.90M(-23.6%)
$560.70M(+6.7%)
Mar 2020
-
$170.10M(+22.4%)
$525.40M(+22.3%)
Dec 2019
$429.60M(+12.1%)
$139.00M(+14.2%)
$429.60M(+14.2%)
Sep 2019
-
$121.70M(+28.6%)
$376.10M(+4.3%)
Jun 2019
-
$94.60M(+27.3%)
$360.60M(-4.6%)
Mar 2019
-
$74.30M(-13.1%)
$378.00M(-1.3%)
Dec 2018
$383.10M(+40.5%)
$85.50M(-19.5%)
$383.10M(-5.5%)
Sep 2018
-
$106.20M(-5.2%)
$405.24M(+13.0%)
Jun 2018
-
$112.00M(+41.1%)
$358.69M(+19.0%)
Mar 2018
-
$79.40M(-26.2%)
$301.54M(+10.6%)
Dec 2017
$272.60M(-46.7%)
$107.64M(+80.4%)
$272.60M(-13.6%)
Sep 2017
-
$59.65M(+8.8%)
$315.38M(-15.7%)
Jun 2017
-
$54.85M(+8.7%)
$374.28M(-18.3%)
Mar 2017
-
$50.46M(-66.5%)
$458.27M(-10.5%)
Dec 2016
$511.90M(-24.5%)
$150.41M(+26.9%)
$511.90M(-5.1%)
Sep 2016
-
$118.56M(-14.6%)
$539.26M(-4.9%)
Jun 2016
-
$138.84M(+33.4%)
$566.81M(-15.1%)
Mar 2016
-
$104.09M(-41.4%)
$667.87M(-1.5%)
Dec 2015
$677.93M(+103.6%)
$177.78M(+21.7%)
$677.93M(+9.8%)
Sep 2015
-
$146.10M(-39.1%)
$617.70M(+12.0%)
Jun 2015
-
$239.89M(+110.1%)
$551.37M(+44.2%)
Mar 2015
-
$114.16M(-2.9%)
$382.35M(+14.8%)
Dec 2014
$333.01M(+113.0%)
$117.54M(+47.4%)
$333.01M(+17.1%)
Sep 2014
-
$79.77M(+12.6%)
$284.44M(+20.3%)
Jun 2014
-
$70.87M(+9.3%)
$236.36M(+18.2%)
Mar 2014
-
$64.82M(-6.0%)
$199.94M(+27.9%)
Dec 2013
$156.32M(+216.8%)
$68.98M(+117.7%)
$156.32M(+52.5%)
Sep 2013
-
$31.69M(-8.0%)
$102.51M(+26.5%)
Jun 2013
-
$34.45M(+62.5%)
$81.07M(+36.3%)
Mar 2013
-
$21.20M(+39.8%)
$59.48M(+20.6%)
Dec 2012
$49.34M(-13.8%)
$15.16M(+48.0%)
$49.34M(+8.5%)
Sep 2012
-
$10.25M(-20.4%)
$45.46M(+3.1%)
Jun 2012
-
$12.87M(+16.4%)
$44.11M(-4.3%)
Mar 2012
-
$11.05M(-2.1%)
$46.11M(-19.4%)
Dec 2011
$57.22M(-42.6%)
$11.29M(+26.9%)
$57.22M(-26.8%)
Sep 2011
-
$8.90M(-40.1%)
$78.19M(-14.4%)
Jun 2011
-
$14.86M(-32.9%)
$91.39M(-7.8%)
Mar 2011
-
$22.17M(-31.3%)
$99.11M(-0.6%)
Dec 2010
$99.69M(+2.4%)
$32.26M(+46.0%)
$99.69M(+11.1%)
Sep 2010
-
$22.10M(-2.1%)
$89.74M(-0.3%)
Jun 2010
-
$22.58M(-0.7%)
$89.97M(-8.3%)
Mar 2010
-
$22.74M(+1.9%)
$98.14M(+0.8%)
Dec 2009
$97.32M(+179.2%)
$22.32M(-0.1%)
$97.32M(+7.2%)
Sep 2009
-
$22.33M(-27.4%)
$90.74M(+16.7%)
Jun 2009
-
$30.75M(+40.3%)
$77.74M(+44.7%)
Mar 2009
-
$21.92M(+39.2%)
$53.73M(+54.1%)
Dec 2008
$34.86M
$15.74M(+68.7%)
$34.86M(+16.8%)
Sep 2008
-
$9.33M(+38.4%)
$29.85M(+18.4%)
DateAnnualQuarterlyTTM
Jun 2008
-
$6.74M(+121.3%)
$25.21M(+24.2%)
Mar 2008
-
$3.05M(-71.6%)
$20.30M(+10.0%)
Dec 2007
$18.45M(+556.2%)
$10.73M(+128.7%)
$18.45M(+106.7%)
Sep 2007
-
$4.69M(+156.8%)
$8.92M(+84.0%)
Jun 2007
-
$1.83M(+52.6%)
$4.85M(+44.2%)
Mar 2007
-
$1.20M(-0.9%)
$3.36M(+19.6%)
Dec 2006
$2.81M(-43.4%)
$1.21M(+95.8%)
$2.81M(+43.9%)
Sep 2006
-
$617.00K(+81.5%)
$1.95M(-36.0%)
Jun 2006
-
$340.00K(-47.4%)
$3.05M(-28.2%)
Mar 2006
-
$646.00K(+84.0%)
$4.25M(-14.4%)
Dec 2005
$4.96M(-19.6%)
$351.00K(-79.5%)
$4.96M(-16.4%)
Sep 2005
-
$1.72M(+11.6%)
$5.94M(-9.1%)
Jun 2005
-
$1.54M(+13.2%)
$6.54M(-0.2%)
Mar 2005
-
$1.36M(+2.4%)
$6.55M(+6.1%)
Dec 2004
$6.17M(-79.2%)
$1.33M(-42.7%)
$6.17M(+0.7%)
Sep 2004
-
$2.31M(+49.5%)
$6.13M(-14.9%)
Jun 2004
-
$1.55M(+57.2%)
$7.20M(-32.3%)
Mar 2004
-
$985.00K(-23.3%)
$10.64M(-64.1%)
Dec 2003
$29.66M(-13.7%)
$1.28M(-62.0%)
$29.66M(-31.9%)
Sep 2003
-
$3.39M(-32.0%)
$43.54M(-10.2%)
Jun 2003
-
$4.98M(-75.1%)
$48.47M(-3.8%)
Mar 2003
-
$20.00M(+31.9%)
$50.37M(+46.6%)
Dec 2002
$34.37M(+318.0%)
$15.17M(+82.4%)
$34.37M(+57.7%)
Sep 2002
-
$8.32M(+20.9%)
$21.80M(+43.0%)
Jun 2002
-
$6.88M(+72.0%)
$15.25M(+44.1%)
Mar 2002
-
$4.00M(+53.8%)
$10.58M(+28.7%)
Dec 2001
$8.22M(+26.6%)
$2.60M(+47.1%)
$8.22M(+21.1%)
Sep 2001
-
$1.77M(-20.2%)
$6.79M(+12.0%)
Jun 2001
-
$2.21M(+34.7%)
$6.06M(-4.8%)
Mar 2001
-
$1.64M(+41.0%)
$6.37M(-2.0%)
Dec 2000
$6.50M(+13.9%)
$1.17M(+11.9%)
$6.50M(+6.0%)
Sep 2000
-
$1.04M(-58.7%)
$6.13M(-2.5%)
Jun 2000
-
$2.52M(+42.2%)
$6.29M(-2.8%)
Mar 2000
-
$1.77M(+121.4%)
$6.47M(+13.5%)
Dec 1999
$5.70M(+90.0%)
$800.00K(-33.3%)
$5.70M(+3.6%)
Sep 1999
-
$1.20M(-55.6%)
$5.50M(-1.8%)
Jun 1999
-
$2.70M(+170.0%)
$5.60M(+80.6%)
Mar 1999
-
$1.00M(+66.7%)
$3.10M(+3.3%)
Dec 1998
$3.00M(+42.9%)
$600.00K(-53.8%)
$3.00M(0.0%)
Sep 1998
-
$1.30M(+550.0%)
$3.00M(+42.9%)
Jun 1998
-
$200.00K(-77.8%)
$2.10M(+16.7%)
Mar 1998
-
$900.00K(+50.0%)
$1.80M(-14.3%)
Dec 1997
$2.10M(-75.6%)
$600.00K(+50.0%)
$2.10M(0.0%)
Sep 1997
-
$400.00K(-500.0%)
$2.10M(-4.5%)
Jun 1997
-
-$100.00K(-108.3%)
$2.20M(-56.0%)
Mar 1997
-
$1.20M(+100.0%)
$5.00M(-41.9%)
Dec 1996
$8.60M(+160.6%)
$600.00K(+20.0%)
$8.60M(-19.6%)
Sep 1996
-
$500.00K(-81.5%)
$10.70M(+0.9%)
Jun 1996
-
$2.70M(-43.8%)
$10.60M(+32.5%)
Mar 1996
-
$4.80M(+77.8%)
$8.00M(+142.4%)
Dec 1995
$3.30M(-52.2%)
$2.70M(+575.0%)
$3.30M(+3200.0%)
Sep 1995
-
$400.00K(+300.0%)
$100.00K(-75.0%)
Jun 1995
-
$100.00K(0.0%)
$400.00K(-73.3%)
Mar 1995
-
$100.00K(-120.0%)
$1.50M(-78.3%)
Dec 1994
$6.90M(-32.4%)
-$500.00K(-171.4%)
$6.90M(-55.5%)
Sep 1994
-
$700.00K(-41.7%)
$15.50M(-3.1%)
Jun 1994
-
$1.20M(-78.2%)
$16.00M(+3.2%)
Mar 1994
-
$5.50M(-32.1%)
$15.50M(+52.0%)
Dec 1993
$10.20M(+385.7%)
$8.10M(+575.0%)
$10.20M(-121.3%)
Sep 1993
-
$1.20M(+71.4%)
-$47.80M(-2755.6%)
Jun 1993
-
$700.00K(+250.0%)
$1.80M(0.0%)
Mar 1993
-
$200.00K(-100.4%)
$1.80M(-14.3%)
Dec 1992
$2.10M(+110.0%)
-$49.90M(-198.2%)
$2.10M(-96.0%)
Sep 1992
-
$50.80M(+7157.1%)
$52.00M(+4233.3%)
Jun 1992
-
$700.00K(+40.0%)
$1.20M(+140.0%)
Mar 1992
-
$500.00K
$500.00K
Dec 1991
$1.00M
-
-

FAQ

  • What is Regeneron Pharmaceuticals annual capital expenditures?
  • What is the all time high annual CAPEX for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual CAPEX year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly CAPEX year-on-year change?
  • What is Regeneron Pharmaceuticals TTM capital expenditures?
  • What is the all time high TTM CAPEX for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals TTM CAPEX year-on-year change?

What is Regeneron Pharmaceuticals annual capital expenditures?

The current annual CAPEX of REGN is $881.60M

What is the all time high annual CAPEX for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual capital expenditures is $1.62B

What is Regeneron Pharmaceuticals annual CAPEX year-on-year change?

Over the past year, REGN annual capital expenditures has changed by -$44.80M (-4.84%)

What is Regeneron Pharmaceuticals quarterly capital expenditures?

The current quarterly CAPEX of REGN is $271.50M

What is the all time high quarterly CAPEX for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly capital expenditures is $1.07B

What is Regeneron Pharmaceuticals quarterly CAPEX year-on-year change?

Over the past year, REGN quarterly capital expenditures has changed by +$109.70M (+67.80%)

What is Regeneron Pharmaceuticals TTM capital expenditures?

The current TTM CAPEX of REGN is $991.30M

What is the all time high TTM CAPEX for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high TTM capital expenditures is $1.75B

What is Regeneron Pharmaceuticals TTM CAPEX year-on-year change?

Over the past year, REGN TTM capital expenditures has changed by +$182.20M (+22.52%)
On this page